Literature DB >> 10925113

Petroleum jelly lipogranuloma of the penis treated with excision and native skin coverage.

R A Santucci1, R D Zehring, D McClure.   

Abstract

Penile augmentation by injection of petroleum jelly is still performed by nonmedical practitioners abroad and causes foreign body reactions with resultant scarring, deformity, and ulceration. Surgical treatment involves removal of the foreign material and granuloma, followed by scrotal flaps, inguinal flaps, free flaps, or split-thickness skin grafts. We present the use of native penile skin for coverage after resection of oleogranuloma in the first case of which we are aware. Local penile skin coverage allows for an excellent surgical result, with many potential advantages over flaps or skin grafts.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10925113     DOI: 10.1016/s0090-4295(00)00625-7

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  4 in total

1.  Mineral Oil-induced Sclerosing Lipogranuloma of the Penis.

Authors:  Marc A Bjurlin; Jens Carlsen; Mark Grevious; Michael D Jordan; Aisha Taylor; Naveen Divakaruni; Courtney M P Hollowell
Journal:  J Clin Aesthet Dermatol       Date:  2010-09

2.  Self injection of foreign materials into the penis.

Authors:  U Ahmed; A Freeman; A Kirkham; D J Ralph; S Minhas; A Muneer
Journal:  Ann R Coll Surg Engl       Date:  2016-11-21       Impact factor: 1.891

3.  Complications of penile self-injections: investigation of 680 patients with complications following penile self-injections with mineral oil.

Authors:  Johannes Nordsteien Svensøy; Valentine Travers; Palle Jörn Sloth Osther
Journal:  World J Urol       Date:  2017-10-28       Impact factor: 4.226

4.  An unusual delayed complication of paraffin self-injection for penile girth augmentation.

Authors:  Mario De Siati; Oscar Selvaggio; Giuseppe Di Fino; Giuseppe Liuzzi; Paolo Massenio; Francesca Sanguedolce; Giuseppe Carrieri; Luigi Cormio
Journal:  BMC Urol       Date:  2013-12-01       Impact factor: 2.264

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.